MAOB and non-small cell lung carcinoma: Depending on a target-based approach for several enzymes (especially MAO-B due to its overexpression in cancerous lung tissue), Son et al. screened many TOM-derived compounds as candidate potential radio-sensitizing agents for NSCLC.